Engagement of the receptor for advanced glycation end products (RAGE) by its signal transduction ligands is implicated in the development and progression of atherosclerosis. TNFa, a proinflammatory cytokine, is a potent inducer of RAGE expression in endothelial cells. In the present study, we demonstrate that reactive oxygen species (ROS) generated by TNFa stimulated human umbilical vein endothelial cells (HUVECs) induce RAGE expression. The complex III of mitochondrial respiratory chain appears to be the primary source of ROS. The gp91phox subunit of NADPH oxidase appears to be the source of ROS that induces TNFa-dependent mitochondrial ROS generation and subsequent RAGE expression. We also demonstrate that the ROS-mediated RAGE induction occurs via activation of NF-nB, a proinflammatory transcription factor. Thus, stimulation of HUVECs by TNFa evokes the following sequence of events: stimulation of NADPH oxidase Y generation of ROS Y activation of the mitochondrial respiratory chain Y stimulation of NF-nB activity Y induction of RAGE expression. D
Introduction
Cardiovascular diseases are the leading causes of death (up to 80%) in diabetic subjects worldwide [1] . In diabetes, the receptor for advanced glycation end products (RAGE), a member of the immunoglobulin superfamily of cell surface proteins [2] , acts as a progression factor of the vascular disease by amplifying inflammatory and immune responses [3, 4] both in experimental animal models [5] and in human subjects [6] .
A number of studies suggest the mechanism of action of RAGE in evoking vascular disease. RAGE interacts with numerous ligands including advanced glycation end products (AGEs), s100/calgranulins and amphoterin. The interaction of RAGE with its ligands generates reactive oxygen species (ROS), and ROS generated by the RAGE -ligand interactions in turn propagate proinflammatory and prooxidative events [7, 8] . These proinflammatory and prooxidative events contribute to the progression of various pathophysiological processes not only in diabetes [3] [4] [5] [6] , but also in a number of other disorders including rheumatoid arthritis [9] , atherosclerosis [10] , inflammatory kidney disease [11] , inflammatory bowl disease [12] , sepsis [13] , Alzheimer's disease [14] , wound healing [15] , and tumor growth and metastasis [16] . Thus, ROS generated by RAGE -ligand interactions profoundly influence numerous pathologic processes. What is not known is whether ROS can also modulate the expression of RAGE and by so doing establish a self-amplifying cycle.
Recently, TNFa, a proinflammatory cytokine, was shown to induce RAGE expression [17] . TNFa appears to be involved in diabetes-related cardiovascular disorders [18, 19] . The molecular and cellular mechanisms through which TNFa induces RAGE expression are not fully elucidated. It is known that TNFa exerts proinflammatory signals in various cells through enhanced generation of ROS [20 -23] .
Upon this background, the aims of the present investigation were to identify and define the cellular signaling events in TNFa-induced RAGE expression in human umbilical vein endothelial cells (HUVEC). The study explores the role of ROS in TNFa-dependent RAGE expression, the endogenous sources of ROS in HUVEC and the signaling pathways by which RAGE is induced.
Materials and methods

Chemicals
Medium M199, HEPES buffer and collagenase-type 1 were obtained from Invitrogen Corporation. Charcoal/ dextran-treated FBS and untreated FBS were obtained from Hyclone Laboratories. Gelatin, endothelial-derived growth factor, N-acetylcysteine (NAC), allopurinol, TNFa, apocynin, rotenone, myxothiazol, carbonyl cyanide, nitroblue tetrazolium (NBT) and purified cytochrome c were obtained from Sigma Chemical Co. GAPDH primers were obtained from Biomol. Monoclonal anti-RAGE, anti-cytochrome c, anti-GAPDH and HRP-conjugated secondary antibodies were obtained from Chemicon International. Polyclonal anti-gp91phox was a kind gift from Dr. Mark Quinn, Montana State University.
Isolation, culture and treatment of human umbilical vein endothelial cells (HUVECs)
HUVECs were harvested and cultured as described previously [24, 25] . Prior to each experiment, HUVECs were washed with and kept overnight in M199 medium containing 1 mM l-glutamine and antibiotics, but no serum, growth factors, heparin or phenol red. The cells were provided with fresh medium just before starting the experiments. In some experiments, the cells were pre-incubated with NAC, or various oxidase or mitochondrial respiratory chain inhibitors for 1 h, or with antisense/sense oligodeoxynucletides for 6 h followed by treatment with 10 ng/ml of TNFa for up to 4 h.
Semiquantitative RT-PCR
The primers for gp91phox were designed as described before [26] . For semiquantitative PCR, the same conditions and same amount of RNA were used for a varying number of cycles (from 15 to 35 cycles). Between 15 and 22 cycles, there was very little increase of PCR product. A steady state linear increase of product was observed from 23 to 32 cycles after which the increase of product was nonlinear. Based on these results, quantitation of the PCR product was done at 32 cycles. Human GAPDH was used as an internal control.
Transfection of HUVECs with antisense/sense oligonucleotides
Phosphorothioate-modified oligodeoxynucleotides (ODN) were designed and synthesized as reported previously [27] . The antisense/sense ODN and SuperFect transfection reagent mixture were added as per standard protocol to 40% confluent HUVEC in six well plates and incubated at 37 -C for 6 h. Following transfection, the cells were treated with TNFa and respective specific inhibitors, and subsequently the level of RAGE protein was determined.
Preparations of whole cell extracts, immunoprecipitation and Western blot analysis
Immmunoprecipitation of gp91phox [28] and Western blotting [24] were performed as described previously. For Western blot analysis, membranes were treated with primary antibodies of anti-RAGE (1:1500) or anti-gp91phox antibodies (1:1000) O/N at 4 -C. HRP-conjugated secondary antibodies were used at 1:20,000 dilution. Signals were developed using the ECL detection system (Amersham Bioscience).
Subcellular fractionations of cytosol and detection of cytochrome c release
Subcellular fractionation of cytosol was performed as described previously [29] . For Western blot analysis of cytochrome c, membranes were treated with anti-cytochrome c antibody (1:400) O/N at 4 -C. The secondary antibody treatment and signal detection were presented in Western blotting section.
Preparations of nuclear extracts and electrophoretic mobility shift assay (EMSA)
EMSA was performed as described previously with modifications [24] . The consensus NF-nB sequence that was used for radiolabeling with 32 p-ATP was AGTT-GAGGGGACTTTCCCAGGC (5V-3V ). The assays were performed using a Nushift Kit (Active Motif) with 10 Ag of nuclear extract from each experimental condition and 60 pmol of radiolabeled oligonucleotides. For supershift assay, 4 Al of rabbit polyclonal antibody of NF-nB-p65 were used and diluted according to manufacturer's (Active Motif) protocol.
NBT assay for detection of ROS
The NBT assay was performed as described previously with modifications [30, 31] . Briefly, HUVECs were grown in a Labtek Chamber (NUNC) and treated with 50 AM of NBT for 30 min at 37 -C. Cells were then washed with PBS and fixed with ice-cold 70% methanol. Following fixation, the cells were washed 3 -4 times with room temperature methanol and air-dried. The blue colored formazan content of the cells was then solubilized with 960 Al of 2 M KOH and 1120 Al of DMSO, and the OD was measured spectrophotometrically at 630 nM.
Statistical analysis
Values are expressed as mean T S.D. and were obtained from three separate experiments in each group. Differences between the groups were assessed by one-way analysis of variance and Newman -Keuls multiple comparison tests. Results having P values < 0.05 are considered as significant.
Results
TNFa induces RAGE in HUVECs
Incubation of HUVECs with TNFa increased the level of RAGE expression in a dose-and time-dependent manner with maximum effect noted at 10 ng/ml (98 T 7%) as demonstrated by Western blot analysis ( Figs. 1  and 2) . The time course experiments demonstrated that HUVEC, when treated with 10 ng/ml of TNFa, increased their level of RAGE protein as early as 2 h. RAGE protein level reached a peak value within 4 -6 h and remained at that level for 7 -8 h after which they slowly declined. Based on these results, 10 ng/ml of TNFa for 4 h treatment were used for all the subsequent experiments to investigate TNFa-dependent RAGE expression.
NAC inhibits TNFa-dependent generation of ROS and expression of RAGE in HUVEC
A significant induction of TNFa-dependent ROS generation was observed when HUVECs were treated with 10 ng/ml of TNFa for 25 min (Fig. 3A) . To begin to investigate the relationship between ROS generation and the subsequent expression of RAGE, HUVECs were pre-incubated with the antioxidant NAC. The TNFadependent ROS generation was inhibited dose dependently by incubating HUVECs for 1 h with NAC (10 -30 mM) prior to the treatment with TNFa (Fig. 3A) . Concurrently, NAC prevented TNFa-mediated RAGE induction in HUVECs (Fig. 3) . These results indicate that TNFa-mediated RAGE induction is due, at least in part, to ROS. 
Source(s) of ROS in TNFa-dependent expression of RAGE in HUVEC
We next investigated the source(s) of ROS responsible for RAGE induction in TNFa-stimulated HUVECs. The endogenous sources that contribute to the generation of ROS in HUVECs include nitric oxide synthases, the molybdenum hydroxylases, particularly xanthine oxidoreductase, the mitochondrial electron transport chain, and NADPH or NADH oxidase. To investigate the role of eNOS and xanthine oxidoreductase, HUVECs were pre-incubated for 1 h with L-NAME or allopurinol, the respective specific inhibitors, prior to treatment with TNFa. Both L-NAME and allopurinol failed to inhibit TNFa-induced RAGE expression (data not shown) indicating that neither eNOS nor xanthine oxidoreductase was involved in the TNFadependent RAGE expression.
TNFa is known to stimulate generation of ROS from mitochondria under certain experimental conditions [21 -23] . To determine the importance of the mitochondrial respiratory chain on TNFa-induced generation of ROS and their subsequent effect in TNFa-dependent expression of RAGE, HUVECs were treated with inhibitors of various complexes of the mitochondrial respiratory chain and the generation of ROS and RAGE expression were determined. Rotenone, a mitochondrial complex I-specific inhibitor, at a relatively high concentration (1 AM) marginally inhibited TNFa-dependent generation of ROS (28%) and RAGE expression (38 T 4%) as revealed by NBT reduction and Western blot analysis, respectively (Fig. 4) . At a lower concentration, rotenone had no effect on either TNFa-dependent ROS generation or RAGE expression. In contrast, both TNFa-dependent ROS generation and RAGE expression were inhibited almost completely by preincubating HUVECs with 1 AM concentration of myxothiazol and carbonyl cyanide, mitochondrial complex III and complex IV specific inhibitors, respectively. At 300 nM complex III and complex IV inhibitors had a modest inhibition of ROS generation (32% and 29% respectively) and RAGE expression (45 T 4% and 42 T 4% respectively).
The above findings while indicating a key role for mitochondrial ROS in RAGE induction do not exclude a role for other endogenous oxidases. An NADPH oxidase with similarities to the well-characterized bactericidal NADPH oxidase of phagocytes was recently described as an important source of ROS in vascular endothelial cells [32 -34] . To determine the possible role of this oxidase, HUVECs were treated for 1 h with apocynin (4-hydroxy-3methoxy-acetophenone), a selective inhibitor of NADPH oxidase enzymes [35, 36] , prior to the treatment with TNFa. Apocynin inhibited both TNFa-dependent ROS generation and RAGE expression (Fig. 5) . These results implicate NADPH oxidase(s) as an additional source of ROS in TNFa mediated RAGE induction in HUVECs.
Role of gp91phox in TNFa-induced mitochondrial activation of RAGE induction
NADPH oxidase is a multi-subunit complex [37] . The gp91phox (or homologue) subunit of NADPH oxidase is responsible for electron transfer from NADPH via FAD to heme and finally to molecular oxygen. By using RT-PCR and Western blot analysis, we observed that TNFa modestly increased both gp91phox mRNA and protein expression (data not shown). More interestingly, transfection with the antisense ODN of gp91phox dose dependently inhibited both the TNFa-dependent generation of ROS and expression of RAGE (Fig. 6) , indicating the involvement of gp91phox in the process. The sense ODN of gp91phox had no statistically significant effect on TNFa-dependent ROS generation and RAGE expression, indicating specificity of the action of antisense ODN of gp91phox in the process.
It is known that proinflammatory/prooxidative stimuli cause mitochondria to release cytochrome c into the cytoplasm [38] . To assess the relationship between NADPH oxidase activation and release of cytochrome c from mitochondria, HUVECs were pretreated with apocynin or transfected with antisense ODN of gp91phox followed by treatment with 10 ng/ml TNFa for 25 min and cytochrome c release into the cytoplasm was determined. Western blot analysis of the cytosolic fraction showed that TNFa stimulated the release of cytochrome c from the mitochondria into the cytosol. The cytochrome c release was inhibited dose dependently by apocynin or the antisense ODN of gp91phox, but not by a sense ODN (Figs. 7 and 8 ). This result indicates that mitochondrial activation by TNFa occurs as a consequence of NADPH activation. 
Role of NF-jB in TNFa-induced RAGE expression
To assess the involvement of NF-nB as a downstream target of mitochondrial ROS generation, HUVECs were treated with 10 ng/ml of TNFa for 35 min either alone or after 1 h pretreatment with either mitochondrial respiratory complex inhibitors or the NADPH oxidase inhibitor apocynin. Nuclear extracts were prepared from these cells and EMSA performed using a labeled NF-nB-p65 oligonucleotide. Specificity of the complexes was determined by competition with an excess of unlabeled oligonucleotide, with a labeled mutant oligonucleotide and by super-shift analysis with an affinity-purified polyclonal antiserum to NF-nB-p65. The results of these experiments indicate that the complex III and complex IV inhibitors prevented TNFadependent translocation of NF-nB, whereas the effect of a complex I inhibitor was minimal (Fig. 9) . Apocynin also dose-dependently inhibited TNFa-dependent NF-nB activation (Fig. 10) . Finally, to assess the role of NF-nB in the TNFa-dependent RAGE expression HUVEC were transfected with 300 nM, 1 AM or 3 AM concentrations of antisense ODN of NF-nB-p65 for 6 h followed by treatment with TNFa for 4 h. The antisense ODN of NF-nB-p65 dose-dependently inhibited TNFa-dependent RAGE expression, confirming the involvement of NF-nB in the TNFa-dependent expression of RAGE (data not shown).
Discussion
In a number of pathophysiological disorders, RAGE acts as a progression factor of the disease by amplifying inflammatory and immune responses [3 -16] . Although it is established that interaction of RAGE with its various ligands induces ROS generation and subsequent proinflammatory interactions via the activation of NADPH oxidase and NF-nB [7, 8] , it is yet to be established whether ROS can induce RAGE expression. TNFa, a proinflammatory cytokine, induces ROS generation and NF-nB translocation through the activation of NADPH oxidase or the mitochondrial respiratory chain [20 -23] . This may lead to proinflammatory process or cell death [39, 40] . Moreover, TNFa was shown to induce RAGE expression [17] . Based on the overall action of TNFa, we hypothesized that ROS may be an important intermediate signaling molecule through which TNFa induces RAGE expression. Our results indicate that stimulation of HUVEC with TNFa generates ROS through NADPH oxidase and the mitochondrial respiratory chain. The ROS subsequently activate NF-nB that in turn induce RAGE expression.
In the present investigation, NAC, a widely employed antioxidant that prevents the effects of ROS in various cells [41, 42] , inhibited TNFa-dependent ROS detection and RAGE expression (Fig. 3) . This provided initial evidence of a role for ROS in TNFa-dependent RAGE expression.
To further pursue the role of ROS and to identify the endogenous source(s) of TNFa-induced ROS, we next determined the effects of inhibitors with relative specificity for ROS generating enzymes. Neither the eNOS synthase inhibitor L-NAME nor the xanthine oxidoreductase inhibitor allopurinol prevented TNFa-dependent RAGE expression, eliminating these enzymes as sources of ROS in the signaling events (data not shown).
Mitochondria are major sources of ROS in many cells. In mitochondria, superoxide is generated as a byproduct during the flow of electrons through four inner membrane associated enzyme complexes (complexes I, II, III, IV) to molecular oxygen [43, 44] . Interestingly, in both endothelial and non-endothelial cells mitochondria are targets of proinflammatory cytokines, especially TNFa that uncouples the mitochondrial electron transport chain and induces the release of ROS [21 -24] . To investigate the potential contribution of mitochondria to TNFa-induced ROS generation in HUVEC, inhibitors with specificity for the respiratory chain complexes were employed. These experiments demonstrated that complexes III and IV are important sites of the TNFa-dependent ROS generation and RAGE expression in HUVECs, whereas the role of complex I and complex II appears minimal (Fig. 4) . At this point, we do not know the exact basis for the inhibition of ROS generation by the complex IV inhibitor carbonyl cyanide.
The findings, while indicating a key role for mitochondrial ROS in RAGE induction, did not exclude a role for other endogenous oxidases. Recently, vascular tissue has been demonstrated to contain NADPH oxidases that are similar to the multicomponent phagocyte oxidase, which has been well characterized over the past three decades and contains the catalytic subunit gp91phox [37, 45] . The discovery of this family of superoxide-generating homologues of gp91phox has led to the concept that ROS are generated by NADPH oxidases in many types of cells, including vascular endothelial cells [32 -34] , and perform distinctive cellular functions related to signal transduction. In our experimental system, treatment of HUVECs with TNFa caused ROS generation. This TNFa-dependent ROS generation and RAGE expression were inhibited by apocynin, a specific inhibitor of NADPH oxidases [35, 36] (Fig. 5) . The results suggest that as a consequence of TNFa stimulation, NADPH oxidase generates ROS that in turn initiate TNFa-dependent RAGE expression. Previous studies established that interaction of RAGE with its various ligands activates NADPH oxidase-dependent ROS generation [7, 8] . Thus, based on previous investigations and the present results, we propose a self-amplifying cycle of RAGE expression via enhanced generation of ROS.
Gp91phox is the catalytic subunit of the classical NADPH oxidase of phagocytes [45] . Importantly, transfection with antisense ODN of gp91phox prior to the treatment with TNFa dose dependently inhibited both the TNFadependent ROS generation and RAGE expression (Fig.  6) . This indicates the importance of gp91phox in the TNFa-dependent RAGE expression in HUVEC.
To determine the relationship between ROS generated from NADPH oxidase and that released from mitochondria we evaluated the effect of apocynin and antisense ODN of gp91phox on TNFa-induced cytochrome c release from mitochondrial membranes into the cytosol. We observed that TNFa-dependent cytochrome c release into the cytosol was inhibited by apocynin (Fig. 7) as well as by transfection with antisense ODN of gp91phox (Fig. 8) . These results indicate that cytochrome c activation occurs as a consequence of NADPH oxidase activation. Interestingly, the specific inhibitors of complex III and complex IV of mitochondrial respiratory chain also inhibited the TNFa-dependent induction of gp91phox expression, a subunit of NADPH oxidase (data not shown). This suggests that once activated, mitochondria may control their own generation of ROS by further activating NADPH oxidase through a positive feedback mechanism.
To further pursue the mechanism by which gp91phox and mitochondria may interact, we investigated the possibility of direct interaction between gp91phox and mitochondrial membrane proteins such as cytochrome c. Direct protein -protein interaction between gp91phox and cytochrome c was not observed (data not shown). Thus, we assume that gp91phox and mitochondria interact through ROS. It was previously determined that the degree of activation of mitochondrial ROS generation depends upon the redox state of NADPH [46] . ROS can also affect the mitochondrial membrane potential [47] . Moreover, ROS produced by NADPH oxidase could trigger a burst of mitochondrial ROS generation via activation of the mitochondrial permeability transition pore (MPTP), a phenomena termed ROS-induced ROS release (RIRR) [48] . By using a series of inhibitors and antisense ODN studies, we have demonstrated that ROS produced by NADPH oxidase induce mitochondrial ROS generation. Mitochondrial ROS in turn may stimulate the generation of more ROS by activating NADPH oxidase. We propose the following scenario. Stimulation of HUVEC with TNFa (10 ng/ml to 100 ng/ml) rapidly activates NADPH oxidase resulting in ROS generation that disrupts the mitochondrial membrane potential and induces mitochondria-dependent ROS generation. Subsequently, mitochondria-derived ROS exit the mitochondria and further enhance NADPH oxidase activity. Thus, mitochondria and NADPH oxidase interact via ROS. The validity of this proposal remains to be tested in future experiments.
The final aspect of this investigation evaluated the role of NF-nB as a transcription factor through which ROS generated by NADPH oxidase and the mitochondrial respiratory chain induce RAGE expression. NF-nB is a pleotropic transcription factor [49] that plays a key role in a number of proinflammatory processes [50, 51] . Recent studies indicate that the promoter of the gene encoding RAGE contains multiple NF-nB binding sites [52] . We previously demonstrated that stimulation of HUVECs with TNFa activated NF-nB by phosphorylation of InB [24] . Previous studies from our laboratory also documented that NADPH oxidase was the source of ROS that activates NFnB in melanoma cells [53, 54] . Of note, NF-nB activity is impaired in response to lipopolysaccharide in gp91phox-deficient mice, again demonstrating the importance of NADPH oxidase in the activation of NF-nB [55] . In the present investigation, using gel shift assays we demonstrated that stimulation of HUVEC with TNFa caused rapid translocation of NF-nB that was attenuated dose dependently by inhibitors of mitochondrial respiratory complexes and the NADPH oxidase inhibitor, apocynin (Figs. 9 and 10) . We also observed that NF-nB-p65 was responsible for TNFadependent RAGE expression in HUVEC (data not shown).
The overall sequence of events from TNFa to RAGE expression via ROS generated from NADPH oxidase and mitochondrial respiratory chain is represented through a schematic diagram presented in Fig. 11 . To summarize, TNFa stimulates the generation of ROS in HUVEC via NADPH oxidase and the mitochondrial respiratory chain. The generation of ROS in turn, activates NF-nB as a downstream transcription factor that subsequently induces RAGE expression. ROS are the intermediate signaling molecules through which the mitochondrial respiratory chain and NADPH oxidase interact since inhibition of ROS generation of the mitochondrial respiratory chain affects the ROS generation of NADPH oxidase and viceversa. This is the first report demonstrating the importance of ROS generated by both the mitochondrial respiratory chain and NADPH oxidase in TNFa-dependent induction of RAGE expression in endothelial cells.
